The installation is a collaboration between Vet Sustain and IVC Evidensia, supported by MSD Animal Health.
Laura Gelder-Robertson, CEO of Vet Sustain, said: “We want to show the best of what already exists within veterinary sustainability, to bring to life the business benefits for veterinary teams in a really hands-on, practical way that people can touch and feel and relate back to their everyday practice.
"This is a really positive news story where by sharing knowledge and collaborating across the profession, we can continually improve the health and wellbeing of animals, people, the environment and business.”
https://vetsustain.org/
The awards are an opportunity to acknowledged unsung heroes within the veterinary profession, celebrating those who have made significant contributions to veterinary science, research, clinical practice, education and the welfare of small animals.
The award categories are:
Nominations are welcome from both BSAVA members and non-members.
Nominations will close on 9th January 2026 and the winners will be announced in February 2026.
Adam Gow, BSAVA Honorary Secretary said: “Each year, we’re proud to shine a spotlight on individuals who have truly made a difference in our profession.
"Nominating a colleague is a meaningful way to show appreciation and celebrate the impact they’ve had, so we encourage everyone to get involved and put forward those who inspire them.”
https://www.bsava.com/awards
The bundle includes:
To be in with a chance of winning, take the Lec Medical voucher from the Vet Show voucher book to stand T64.
https://www.lec-medical.co.uk/en-gb
Brainchild of Tom Towey MRCVS, an ECC clinician, the new service allows vets to upload case details, including the level of urgency, and then browse the referral centres that can meet the need, listed by the distance to the practice or to the client and the level of expertise available (eg. Specialist / Advanced Veterinary Practitioner).
The vet then selects the ones that look interesting, presses submit, and the request is sent on their behalf.
The referral practices they've contacted can then reply with their estimate for the procedure and details of when they can see the case.
The owner is notified about each new estimate and can decide which to accept.
When they do, the referral clinic then calls the owner to make an appointment.
Tom highlights part of the Competition and Markets Authority provisional report which says:
"10.16: Our provisional view is that, in a well-functioning market, where multiple referral providers are available and clinically appropriate, we would expect pet owners to be made aware that they can choose a referral provider and to be able to access information about those providers including the nature of the treatment, the skills and experience of the referral vet, the availability of appointments, and, in many cases, the likely cost."
Tom's new service seems to fit the bill precisely.
www.rapidreferrals.co.uk
This, says the company, highlights a missed opportunity for earlier cancer detection, which in turn limits the ability of veterinary teams to improve medical outcomes for their patients.
243 veterinary professionals took part in the survey, most of whom HT Vista says were general practitioners.
On average, they reported seeing 13.5 dermal and subcutaneous masses per vet per week, less than six of which lead to a diagnosis.
HT Vista says around 15% of these lumps will be malignant.
Veterinary oncologist Gillian Dank said: “Every week, thousands of dogs leave practices with undiagnosed masses.
"While many are benign, others are malignant, and delaying diagnosis can mean lost treatment opportunities and poorer prognoses.”
The number one reason why respondents said they don't test more widely is the assumption that a mass is benign by its gross characteristics, followed by owner concerns around cost, time constraints during consultations, and limited access to in-house cytology.
Vista HT Chief Commercial Officer Asher Fink and Managing Director Liron Levy-Hirsch will be presenting “20 dogs in your waiting room with lumps and bumps – how do you spot the 3 with cancer?" at the London Vet Show on 20th November from 1–1:50pm in Exhibitor Showcase Theatre 2
https://info.ht-vet.com/lump-and-bump-survey-results
https://www.cliniciansbrief.com/continuing-education/syllabus/lesson/cracking-code-lumps-bumps-fast-efficient-diagnosis-everyday-practice
https://london.vetshow.com/conference-programme-2025/session-title-coming-soon-38
Photo: www.depositphotos.com
The procedure, called transcatheter edge-to-edge repair (TEER), is a minimally invasive alternative to open heart surgery.
TEER is performed on a beating heart using a specially designed “V-Clamp” device which brings the mitral valve leaflets together, reducing the severity of mitral regurgitation.
The procedure is guided by real-time 3D echocardiography and performed via a small thoracotomy, typically 6–8 cm in length.
CVS, which owns Bristol Vet Specialists, says dogs undergoing TEER generally experience a rapid recovery, with most discharged within 48 hours and minimal need for intensive care.
The company says that once heart failure is diagnosed, the average survival time is between nine and 12 months, but that after TEER surgery, 95% of dogs are discharged successfully, and 85% survive for two years post surgery.
The procedure costs £12,000.
http://www.bristolvetspecialists.co.uk
Miss Davies faced four charges:
Miss Davies made no admissions to any of the charges.
Miss Davies wrote to the College prior to the hearing stating that she would not be attending and she was not represented.
The Committee found all charges bar one proved.
Charge 1a, relating to the anaesthesia increase, was found not proved due to lack of evidence.
In deciding on whether the proven facts amounted to serious professional misconduct, the Committee took into account the aggravating factor that all charges caused risk of injury to an animal or human.
There were no mitigating factors.
The Committee found that Miss Davies’ conduct indicated an unwillingness and inability to act according to the veterinary surgeons’ instructions/directions.
It noted that Miss Davies acted on at least seven occasions contrary to the instructions given or without seeking direction or authorisation, despite her position within the surgical team.
It also found that Miss Davies had breached multiple areas of the Code of Professional Conduct for Veterinary Nurses, including the Code obligations that veterinary nurses must make animal health and welfare their first consideration when attending to animals and that veterinary nurses must communicate with veterinary surgeons and each other to ensure the health and welfare of the animal or group of animals.
It therefore found that, with the exception of administering intermittent positive-pressure ventilation without direction or authorisation, the remaining proved facts amounted to serious professional misconduct.
The Committee then went on to consider the most appropriate and proportionate sanction.
In doing so, it took into account aggravating and mitigating factors.
Aggravating factors included that the conduct was sustained over a period of approximately eight months and took place during four separate surgical procedures, and that Miss Davies posed a risk to animals on each occasion.
The Committee considered that there were a number of mitigating factors including the fact that Miss Davies had been on the Register of Veterinary Nurses since 17 January 2006 with no previous disciplinary findings against her, positive testimonials from a colleague working with Miss Davies at the time of the incidents, and the fact that Miss Davies had expressed some remorse in a letter regarding her conduct in relation to charges 3 and 4.
Colin Childs, chairing the Committee and speaking on its behalf, said: “The Committee found that the charges represented a serious departure from the Code of Professional Conduct for Veterinary Nurses and also that there was evidence that Miss Davies had put her own interests before the health and welfare of animals either by not following the instructions of veterinary surgeons or by acting unilaterally, in relation to the administration of medicines or the placement of a catheter or feeding tube during four surgical procedures.
“Since the Committee could not assess Miss Davies’ future risk or her insight in her absence, it therefore decided that removal was the only proportionate sanction because any other sanction would not protect animals or the public in the future without those matters having been adequately assessed.
Such a sanction also met the wider public interest.
“The Committee therefore directed that the Registrar remove Miss Davies from the Register of Veterinary Nurses.”
www.rcvs.org.uk/disciplinary
Vikaly is indicated for the nutritional and medical management of chronic kidney disease in adult and senior cats with proteinuria, from IRIS stage 2.
The new diet delivers the same therapeutic dosage as benazepril tablets (0.5–1 mg/kg bodyweight/day).
Nutrition-wise, Vikaly is low phosphorus (0.5% as fed), has reduced protein (30% as fed), contains omega-3 fatty acids (1.2%, including 0.6% EPA & DHA) and offers high metabolisable energy (416 kcal/100g).
Virbac highlights data showing that CKD remains the leading cause of mortality in cats over five years old and affects up to 40% of feline patients over the age of ten1,2.
The company says administering daily treatment is recognised as a major issue for CKD cat owners with 45% of owners not administering treatment daily as they should and 51% of owners citing administration difficulties as the reason why3.
This new product eliminates the need to administer medication separately, which could completely transform treatment compliance, removing the risk of missed doses and reducing stress for both cats and their owners.
Virbac says that due to the pharmacokinetic profile of benazepril, which is incorporated into the kibble, at an equivalent dose Vikaly displays greater ACE inhibition than benazepril tablets4.
The rate of food consumption also does not affect plasma Benazeprilat levels, ensuring consistent treatment efficacy regardless of the cat’s feeding behaviour5.
Virbac says that in practice, this means that even if the cat being treated consumes less than 50% of their daily ration, efficacy is maintained with ACE activity similar to that of benazepril tablets.
Benazepril has a wide therapeutic margin, tolerated to 20x the minimum effective dose (10mg/kg) for 52 weeks, with the first signs of toxicity being reduced erythrocytes counts & ovary/oviduct weights6.
Virbac says that with Vikaly, these levels cannot be reached because the active ingredient is contained in food, which would require a cat to consume more than 10 times their daily ration.
Vikaly is presented in a 1.5kg bag, which equates to a 30 day supply for a 4.5kg cat with normal bodyweight.
It can be fed alongside wet food, providing that the cat consumes at least 50% of their daily ration before being given the wet food.
The daily ration can also be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and to promote consistent food intake.
Vikaly is a prescription diet. Or 'POD', I guess.
References
Finalists are chosen by a panel of industry leaders on the basis that they embody the qualities that define veterinary excellence: compassion, teamwork, innovation and a relentless commitment to animal welfare.
The finalists this year are:
Vet Nurse of the Year
Vet of the Year
Practice Support Staff of the Year
Practice of the Year
The winners will be announced at the London Vet Show on Thursday 20th.
Good luck, one and all!
Purina says it is common for dogs with gastrointestinal disturbances not to digest fat properly1, resulting in water secretion in the gut and loose stools2, production of anti-inflammatory compounds2 and altered microbiome composition 3,4.
The company says a limited fat diet can help, but some conditions, such as hyperlipidaemia, require even lower fat levels, such as found in the new EN Low Fat diet.
If you go to stand P20 and watch a short video about the new diet, you'll be entered into a draw to with prizes which include shopping vouchers, gym bags and umbrellas.
Vets from the Purina Technical Support Line will also be on the stand to answer questions about the new product.
Zoetis says AI Masses delivers fast, accurate, in-clinic screening of common lymph node and skin/subcutaneous masses in minutes, making Vetscan Imagyst the most capable veterinary AI analyser in the world.
AI Masses uses an algorithm to identify and classify common skin/subcutaneous mass and lymph node aspirates at the point of care.
At additional charge, for added diagnostic confidence, Zoetis also offers expert clinical pathologist reviews via Digital Cytology and Add-on Expert Review within hours.
Abhay Nayak, President, Global Diagnostics at Zoetis said: “By empowering veterinary teams with valuable insights into potentially cancerous cells, we are helping to reduce waiting times and alleviate stress for pet owners facing some of the most challenging moments with their beloved pets.
https://www.zoetisdiagnostics.com/uk/point-of-care
In short, it’s a system which gives clients a breakdown of the options you have recommended, with an explanation of the procedure or treatment, potentially the pros and cons, and the price.
When time permits, this allows the client to consider their options at home, on their own, with the information in front of them, taking away the pressure that sometimes comes with having to make these decisions in front of a veterinary professional.
The system works as a standalone web-based service at present, but integrations with VetIT and Lupa are in development.
Practices can configure the software with their own information about treatment and procedures, but VetConsent has also teamed up with Visiocare and Vetlexicon to provide graphically rich material to help the client understand even better.
The service costs £40 per vet per month.
Chief Veterinary Officer, Nick Lloyd MRCVS said: “We’re confident that the time-savings alone will more than cover the cost of the service, but even more importantly, it improves the service you offer clients and ensures that you’ve covered all the bases in getting informed consent.”
https://vetconsent.com
The company is hosting 14 sessions over the two days, delivering over 8 hours of CPD
Speakers include Tara Ryan, CVS Chief Veterinary Officer, Laurent Garosi, Clinical Director of Vet Oracle Teleradiology, Kieran Borgeat, Specialist in Veterinary Cardiology at Bristol Vet Specialists, Emma Cooper, Head Veterinary Surgeon at Bell Equine, Alan Johnson, Regional Clinical Lead at CVS and Mark Moreton, CVS Director of Learning & Development.
Clinical topics will range from bone marrow biopsies and neurological examinations, to emergency diagnostics and perioperative analgesia.
Professional discussions will focus on clinical freedom or clinical guidance, and why career progression is more than certificates or practice ownership.
Leadership and management sessions will cover supporting new graduates and adopting the right coaching mindset.
Mark Moreton said: “Whether you're a vet, nurse, practice manager or student - there’s something here for everyone.
"CVS Learning Live is designed to help our veterinary colleagues grow, connect, and thrive.
"It reflects our ongoing mission to help every colleague reach their full potential through accessible, high-quality education and peer support.
"We encourage delegates to plan their sessions in now so that they don’t miss out.”
https://london.vetshow.com/conference-programme.
The Clinical Research Project grants support the undertaking for small-scale research projects in companion animals, with the ultimate objective of advancing understanding of the causes and/or management of a clinical disorder.
The awards include funding for:
The projects are expected to be completed by 2028.
https://bsava.com/petsavers
Sarah qualified as an RVN in 2008, and has since had a varied career within veterinary nursing – gaining experience in both clinical and non-clinical roles, with small animals and wildlife, and in primary care and referral settings.
She is currently the senior oncology nurse at a large referral hospital in Surrey.
In her inaugural speech as President at the BVNA AGM, Sarah introduced her presidential theme of compassion and empathy, explaining how she wants to ensure the voice of veterinary nurses is “recognised, respected and represented” not just within veterinary clinics, but across the wider profession and society.
She said: "Compassion and empathy will mean something different to each of us.
"Personally, this theme really aligns with my role as an oncology RVN, whether that is supporting an owner through end-of-life care, hand feeding an inpatient, or making a colleague a cup of tea during a difficult shift.
“I believe this theme showcases the holistic nature of RVNs.
"We embed compassion in every part of our roles and it is at the heart of all we do.
"My vision is that this theme enables us to highlight the impact veterinary nurses have on our patients, their families and those within the profession.
"I am sure we all have an example of when a veterinary nurse’s compassion has made a real difference to someone’s life.
“I hope we can use this opportunity to recognise those that have demonstrated exceptional empathy and compassion within their role, and act as a reminder to show compassion to ourselves whilst working within the veterinary profession.”
The CMA provisional decision was widely seen as less interventional than had been expected, largely demanding transparency over things like pricing, practice ownership and billing, which many practices had already implemented.
However, one provisional decision was that regardless of their status, all veterinary practices should inform owners that they can ask for a written prescription and explain that they may be able to have it fulfilled cheaper online.
Two of the largest online veterinary pharmacies are animed.co.uk, which is owned by CVS, and petdrugsonline, which is owned by IVC.
So in effect, the decision asked independent practices to direct their clients to competitor businesses.
What you might call a bitter pill to swallow.
In the light of the announcement, CVS issued a press release citing the "clarity" afforded by the CMA announcement and the fact that it does not think the CMA's proposed remedies will have a material impact, as factors behind its decision to seek a Main Market listing.
The company has also announced a £20m share buyback programme.
The company says the new framework is designed to help veterinary teams make prescribing decisions which balance animal welfare, public health, and environmental sustainability, the latter especially in the light of recent research which found significant levels of imidacloprid and fipronil - which are toxic to invertebrates - in waterways1,2.
The Lifestyle Parasite Risk Assessment considers the following factors before recommending treatment, including:
Pet-specific behaviours such as scavenging, hunting, or eating raw foodEnvironmental exposure, including outdoor access and swimming habitsHousehold composition, especially the presence of vulnerable individualsTravel history, both domestic and internationalOwner compliance and preferred administration methods
Alongside the new assessment, CVS has launched a training course for all staff who interact with parasiticides, so they can confidently explain the benefits of lifestyle-based prescribing.
The Seller’s Declaration has been revised with the support of British Equestrian (BEF) and British Horse Society (BHS) to make the purchase process more efficient for both buyer and seller.
BEVA says the new Declaration is a more extensive, stand-alone document which the buyer should request from the seller directly before the formal process of the PPE commences.
In this way the seller is obliged to disclose any pertinent information, such as previous lameness, stereotypies, specific management requirements, previous veterinary interventions and details of preventative dental care and worm control, prior to the PPE proceeding.
Lucy Grieve, Veterinary Projects Officer at BEVA, said: “BEVA’s new Seller’s Declaration will iron out the PPE process to make it smoother and more efficient for all three parties involved: buyer, seller and vet.
“The advantage is it cuts out the vet as a middleman… asking if the horse has received any medication, or coughs on dry hay and so on.
“The new Seller’s Declaration means that the seller should declare those things to the buyer straight off.
"If completed in advance, it should give the buyer more robust information on which to base proceeding with the PPE or not.”
https://www.beva.org.uk/Resources/Clinical-resources/PPE-toolkit
Leah won the award for her extraordinary dedication, compassion, unwavering devotion to her patients and professionalism in all aspects of her work, both in practice and outside it.
After graduating from the University of Edinburgh in 2021, Leah began working as a mixed practice vet at Flett and Carmichael Veterinary Surgeons in Orkney, where she always goes the extra mile for her patients, whether within her practice or out and about in the Orkney countryside and coastline.
She is involved with multiple charities outside of work, becoming an Orkney Nature Festival trustee, a British Divers Marine Life Rescue (BDMLR) medic and Scottish Marine Animal Stranding Scheme volunteer.
Her involvement is not confined to daylight hours or predictable situations as she frequently responds to emergency call-outs for seals, porpoise or dolphins at all hours, often in challenging conditions.
It is not uncommon for her to be found on windswept beaches in the dead of night, providing expert care to stranded or injured marine mammals.
She has also been involved in providing first aid to stranded whales and dolphins and assisting in their re-floatation or euthanasia when the animals can’t be refloated due to illness and also assisted with 37 pilot whale postmortems on Sanday, Orkney, in 2024 after the most significant mass stranding event in the UK in the last 100 years.
Leah said: “I am very humbled to even be nominated, let alone win this award, especially when I know how many amazing and talented young vets there are in the UK.
"I truly do love the work that I do, island vetting really is unique and I’m grateful to have the opportunity to help make a difference.”
Rachel Dean won her award for her significant contribution to clinical practice and veterinary education.
Since graduating from the University of Glasgow, she has worked in mixed, dairy and small animal general practice in the private, charity and academic sectors.
"She is passionate about veterinary healthcare and is a recognised international leader of evidence-based veterinary medicine and encourages authentic collective clinical leadership and progressing care through developing professional connections, research, innovation, quality improvement and professional development.
BVA President Rob Williams said: “Rachel's work on evidence-based veterinary medicine (EBVM), including founding the Centre for Evidence-based Veterinary Medicine at University of Nottingham’s School of Veterinary Medicine, has been truly pioneering and she is an impressive educator, having delivered education and mentoring in the fields of feline and shelter medicine.”
Andrew Cunningham won his award for his exceptional contributions to the advancement of veterinary medicine and the field of wildlife veterinary science.
Andrew is currently Deputy Director of Science at ZSL, where he has worked in various roles since 1988.
He has led several national and international, multi-disciplinary wildlife disease research projects investigating the emergence, spread, impact and mitigation of disease threats to wildlife conservation, understanding the role of anthropogenic environmental change on wildlife disease emergence.
His large body of original, high-quality research has had major impacts across conservation biology, veterinary science and public health, informing and influencing the policies of governments, intergovernmental organisations and NGOs.
Polly Compston received her award for her outstanding contribution to animal health and welfare on a global scale.
After graduating from Edinburgh Vet School, Polly worked in mixed and small animal practice before completing a residency in clinical research at Rossdales Equine Hospital alongside an MSc in Veterinary Epidemiology and Public Health.
She went on to work in research for an NGO, developing an evidence base for animal welfare interventions across Asia, Sub-Saharan Africa, and Latin America, and later completed a PhD on the economic and social drivers of foot-and-mouth disease control in Kenya.
She currently has two roles, one as Veterinary Head of Outbreak Central Services at the Animal and Plant Health Agency (APHA), leading licensing, tracing and surveillance teams in the UK’s response to notifiable disease outbreaks, and also as a Technical Lead at EuFMD supporting international efforts for improved transboundary livestock disease control.
Finally, Pet People Vets, 387 Vets and Brooke Action for Working Horses and Donkeys all won a Wellbeing Award for going above and beyond to support staff wellbeing.
Congratulations to one and all!
Dr Butterworth’s practice was a member of TBAS, a Department of Environment, Food and Rural Affairs-funded (Defra) project administered by Farmcare Solutions Ltd which provides advice to eligible farmers via its veterinary partners.
The farm to which the charges relate to was owned by Dr Bexon’s partner. It had no cattle on-site (though was still eligible for the TBAS).
Dr Butterworth was charged with signing a TBAS visit report, in which he was named as the TBAS advisor, relating to a visit to the farm in February 2023 which had, in fact, not taken place and then subsequently signed a report about a follow-up visit in July 2023 which also hadn’t taken place.
Dr Bexon was charged with signing the same two false reports as a representative of the farm in question.
Both faced a secondary charge that their actions were dishonest, misleading and risked undermining procedures relating to public health and animal welfare.
Dr Butterworth and Dr Bexon admitted all the charges against them and that these charges amounted to serious professional misconduct.
The Committee also found that their actions amounted to serious professional misconduct in that they had breached three of the five key principles in the Code of Professional Conduct relating to: honesty and integrity; client confidentiality and trust; and professional accountability.
The Committee also found that the actions of both veterinary surgeons had breached the ’10 principles of certification’ outlined in the supporting guidance to the Code.
Considering Mr Butterworth’s conduct, the Committee found that there were a number of aggravating factors including: the premeditated nature of the conduct as he was the driving force behind the deceit, the fact there was financial gain as his practice would have been paid for the non-existent visits, breach of confidentiality for the farmer, breach of client trust for Farmcare Solutions Ltd, and abuse of professional position as a TBAS advisor.
For Dr Bexon the aggravating factors were breach of confidentiality for the farmer, breach of client trust for Farmcare Solutions Ltd, and the fact that, as a TBAS advisor, she should have known that physical visits to farms within the scheme were mandatory.
Paul Morris, chairing the Disciplinary Committee and speaking on its behalf, said: “The Committee considered both respondents’ conduct was liable to have a seriously detrimental effect on the reputation of the profession and undermined public confidence in the profession and the TBAS process.
"The Committee considered that members of the public would be deeply troubled that registered veterinary surgeons had behaved in this way.”
At the hearing the Committee received a large number of positive testimonials for Dr Butterworth, including three given directly to the Committee – one from a veterinary surgeon colleague and two from farmer clients.
The Committee also considered his lack of previous disciplinary history and otherwise unblemished career, open and frank admissions at an early stage, insight into his misconduct, genuine remorse and positive reflection, efforts to avoid a repetition of behaviours and evidence of a more mature approach to management, lapse of time since the incident.
Taking everything into account the Committee decided reprimanding Dr Butterworth and warning him with regard to future conduct was the most appropriate and proportionate response.
Paul added: “The Committee did give serious consideration to suspending Dr Butterworth’s registration with the College.
"Such a sanction would have sent out a clear message that this sort of behaviour is absolutely not to be tolerated.
"However, in light of the extensive mitigation, his honesty and significant insight throughout these proceedings and the unlikeliness of behaviour of this type ever being repeated, the Committee considered the public would not be best served by suspending an otherwise exemplary veterinary surgeon and that such a sanction would be disproportionate and punitive.”
"In such circumstances, the Committee was satisfied that a reprimand and warning not to behave in this way again, would provide adequate protection to animals and would satisfy the public interest.
"The Committee was persuaded that Dr Butterworth would be most unlikely to make such a flawed set of decisions again.
"Notwithstanding the serious nature of Dr Butterworth’s conduct, the Committee was satisfied that a fully informed member of the public would not be shocked if he were allowed to continue to practise.”
The Committee also received a significant number of positive testimonials for Dr Bexon, with three veterinary surgeon colleagues giving oral evidence to the Committee.
The Committee also considered her lack of disciplinary history and hitherto unblemished career, her open and frank admissions, her insight, remorse and positive reflections, her efforts to avoid repetition of the behaviours and the lapse of time since the event.
Taking everything into account, the Committee decided to reprimand Dr Bexon.
Paul said: “This was not a case where she had been motivated by any financial gain.
"Indeed, everything the Committee had read and heard about her indicated the opposite and furthermore, it was apparent that she had nothing to gain by her actions beyond satisfying Dr Butterworth.
"As already stated, the Committee acknowledged that the role played by Dr Bexon was less than that played by Dr Butterworth.
"Moreover, there was a power imbalance at play and Dr Butterworth was able to take advantage of, albeit unknowingly, Dr Bexon’s lack of self-confidence.”
"The Committee has already indicated that it believed the likelihood of her repeating such behaviour to be non-existent.
"Her significant insight, together with the reflection and remedial work she has undertaken are as much as any person could do.
"She had truly learnt her lesson in the harshest of ways.
"In the Committee’s view she did not represent any risk to animals or the public, indeed quite the contrary as she is a very able vet, in high demand by her clients.”
The increase has prompted a call by Equine Infectious Disease Surveillance (EIDS) for equine professionals and owners to strengthen biosecurity and consider vaccination to help reduce disease spread.
EIDS has been monitoring diagnoses reported to SES and says the data indicates a genuine increase rather than normal year-to-year variation.
With the number of confirmed cases climbing, EIDS and the SES network are urging veterinary professionals and horse owners to revisit their yard management practices, saying that simple but consistent actions, such as isolating new arrivals, disinfecting shared equipment, and post-outbreak screening can make a substantial difference in controlling the disease.
In addition, they recommend the Strangvac vaccine, saying that when combined with good hygiene and daily temperature checking, can help reduce both the risk of infection and onward spread.
Dr Richard Newton of EIDS said, “These findings are a clear reminder that strangles remains an ever-present risk to the UK horse population.
"The increase in diagnoses underlines the importance of continued vigilance, prompt reporting, and proactive prevention measures.”
https://equinesurveillance.org/ses/
IVC is one of 115 companies certified in the UK, including Vodafone, Bentley, Amazon and Pfizer, and the first veterinary organisation.
The certification benchmarks organisations globally on their people practices, including strategy, work environment, talent acquisition, learning, diversity, equity & inclusion, and wellbeing.
IVC says the certification reflects a series of initiatives introduced to enhance the colleague experience, including private healthcare options for all staff, a family-friendly policy, a growing network of wellbeing champions and mental health first aiders, and the launch of two new training centres.
Duncan Phillips, IVC Evidensia CEO UK & Ireland, said: “This certification is a welcome acknowledgement of the progress we’ve made, and a motivator to keep improving the experience for every colleague across the UK.”
Androna Benade, Regional Manager for UK and Ireland, Top Employers Institute said: “With veterinary professionals playing a vital role in animal health, food safety, and public wellbeing, this recognition sends a powerful message about the importance of valuing and investing in the people behind the profession.
"As the UK faces ongoing workforce challenges in the veterinary sector, IVC Evidensia’s achievement sets a benchmark for how the profession can be supported, retained, and celebrated as a critical part of the UK economy and society.”
www.top-employers.com
However, many of the causes of above-inflation increases in the cost of veterinary care go well beyond the remit of the CMA and it therefore has limited scope to propose or enforce changes that will likely have any significant impact on costs.
The CMA concluded that the main barriers to healthy competition are: owners not being given enough information, barriers to owners being able to make appropriate choices and an out-of-date regulatory environment.
To correct these issues, the CMA has proposed that veterinary practices should be compelled to:
Given that treatment inflation, rather than a lack of competition, is likely the biggest contributory factor to rising veterinary costs, it seems unlikely that providing price lists, itemised bills or written estimates will do much more than increase the administrative burden on veterinary practices.
What's more, it is very hard to see how price lists and estimates can ever be truly representative in such a complex area as medicine.
So these proposed measures are no more than rearranging deckchairs on the Titanic.
To switch metaphors, the problem is less that pet owners don't know what they're buying and more that the veterinary profession is trying to sell caviar to people who only want or can afford a Big Mac and large fries.
Real change can only be driven by the veterinary profession - not just veterinary surgeons, but the regulator, universities, manufacturers and others, after reflecting on the real, rather than assumed needs of its clients and patients, together with the ethical issues in play.
A good starting point for that reflection is the new book Veterinary Controversies and Ethical Dilemmas, available now: https://www.routledge.com/Veterinary-Controversies-and-Ethical-Dilemmas-Provocative-Reflections-/Clutton-Murphy-Stephens-Taylor/p/book/9781032579863
The company says Nutramed kills over 99.9% of known bacteria and fungal spores whilst being safe and gentle enough for use on sensitive areas such as around the eyes and mouth.
Lianne O’Boyle RVN and Clinical Lead at Nutravet, said: “Veterinary professionals need a reliable, safe and effective solution for minor wound management and first aid.
"Nutramed hypochlorous spray and gel combine powerful antimicrobial performance with a gentle formula, making it a must-have in every practice and pet owner’s first aid kit.
“Designed to support everyday veterinary care, Nutramed provides peace of mind for professionals and pet owners alike by ensuring minor wounds, cuts, and abrasions are treated quickly and effectively.”
www.nutravet.com.
The new resource contains webinars, vet-written articles and podcasts covering topics including the microbiome, the gut’s role in immunity and toxin ingestion.
The resources support NVS's range of dietary products: Prorestore +, Movipet, Duostart, Glandvet, Activated Charcoal, Duotox and Digestive Paste.
Malcolm Dickinson, Head of Product Management at NVS, said: “The new products are all designed with vets and their patients in mind.
"They’re useful everyday products to help combat some of the most commonly seen conditions in practice.
“We hope the hub will act as a central base of knowledge that veterinary teams can refer back to time and time again.
"The webinar and podcasts in particular are well worth a listen and a watch as they are full of useful information delivered by vets.”
https://www.nvsweb.co.uk/our-brands/select-from-nvs/digestive-health-hub